The presence of DNTs has been demonstrated within lymph node metastases of melanoma in the shape of tolerogenic T cells [19], and their accretion has been described in a serial biopsy of melanoma metastases in patients treated with BRAF and MEK inhibitors [20]. This evidence concerns the gene MAP2K7 and melanoma.